By taking advantage of the Allen Human Brain Atlas (AHBA) and PET-MRI with different tracers to distinctively capture Aβ and tau, Yu and colleagues [3] were able to confirm the existence of a specific sensibility to these two AD hallmarks depending on the spatial location on the brain. The gene discussed is MAPT; the disease is Alzheimer disease.